JPWO2024172003A1 - - Google Patents
Info
- Publication number
- JPWO2024172003A1 JPWO2024172003A1 JP2025501139A JP2025501139A JPWO2024172003A1 JP WO2024172003 A1 JPWO2024172003 A1 JP WO2024172003A1 JP 2025501139 A JP2025501139 A JP 2025501139A JP 2025501139 A JP2025501139 A JP 2025501139A JP WO2024172003 A1 JPWO2024172003 A1 JP WO2024172003A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023022661 | 2023-02-16 | ||
| PCT/JP2024/004718 WO2024172003A1 (ja) | 2023-02-16 | 2024-02-13 | エルゴチオネインを含有する筋萎縮抑制用組成物及びＳｒｃチロシンキナーゼ阻害用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2024172003A1 true JPWO2024172003A1 (https=) | 2024-08-22 |
Family
ID=92420194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025501139A Pending JPWO2024172003A1 (https=) | 2023-02-16 | 2024-02-13 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPWO2024172003A1 (https=) |
| CN (1) | CN120659607A (https=) |
| TW (1) | TW202448445A (https=) |
| WO (1) | WO2024172003A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7759724B2 (ja) * | 2018-06-29 | 2025-10-24 | 長瀬産業株式会社 | エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用 |
| JP7796118B2 (ja) * | 2021-04-26 | 2026-01-08 | サントリーホールディングス株式会社 | 白血球及び／又は好塩基球増加用組成物 |
| WO2024038821A1 (ja) * | 2022-08-17 | 2024-02-22 | サントリーホールディングス株式会社 | フレイル予防又は改善用組成物、及び、加齢に伴う身体活動能力低下を抑制又は改善するための組成物 |
-
2024
- 2024-02-13 JP JP2025501139A patent/JPWO2024172003A1/ja active Pending
- 2024-02-13 CN CN202480011751.5A patent/CN120659607A/zh active Pending
- 2024-02-13 WO PCT/JP2024/004718 patent/WO2024172003A1/ja not_active Ceased
- 2024-02-16 TW TW113105482A patent/TW202448445A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024172003A1 (ja) | 2024-08-22 |
| TW202448445A (zh) | 2024-12-16 |
| CN120659607A (zh) | 2025-09-16 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20260206 |